OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1
Hongzeng Li, Wen Jie Yuan, Yuxin Tian, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 725, pp. 109269-109269
Closed Access | Times Cited: 8
Hongzeng Li, Wen Jie Yuan, Yuxin Tian, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 725, pp. 109269-109269
Closed Access | Times Cited: 8
Showing 8 citing articles:
An Update on the Therapeutic Anticancer Potential of Ocimum sanctum L.: “Elixir of Life”
Mohammad Raghibul Hasan, Bader S. Alotaibi, Ziyad M. Althafar, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1193-1193
Open Access | Times Cited: 29
Mohammad Raghibul Hasan, Bader S. Alotaibi, Ziyad M. Althafar, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1193-1193
Open Access | Times Cited: 29
Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
Lu Wang, Yonghuan Yan, Linfang Wu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106925-106925
Open Access | Times Cited: 26
Lu Wang, Yonghuan Yan, Linfang Wu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106925-106925
Open Access | Times Cited: 26
The gut-liver axis in fatty liver disease: role played by natural products
Ming Zhu, Xie Ruishi, Xu Linyi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Ming Zhu, Xie Ruishi, Xu Linyi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
Qi Zhang, Wenmin Xing, Qiao Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 20
Qi Zhang, Wenmin Xing, Qiao Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 20
L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism
Amany E. Nofal, Hind S. AboShabaan, Walaa A. Fadda, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 732-732
Open Access | Times Cited: 2
Amany E. Nofal, Hind S. AboShabaan, Walaa A. Fadda, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 732-732
Open Access | Times Cited: 2
Extraction of raspberry ketone from red raspberry and its intervention in the non-alcoholic fatty liver disease
Yongqiang Ma, Weiye Xiu, Xin Wang, et al.
Applied Biological Chemistry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 5
Yongqiang Ma, Weiye Xiu, Xin Wang, et al.
Applied Biological Chemistry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 5
Preparation, characterization, oral bioavailability, and pharmacodynamic study of eugenol-porous silica solidified powder
ZhongWei Yao, Wei Zhang, Yehong Hu, et al.
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 4, pp. 1235-1248
Closed Access
ZhongWei Yao, Wei Zhang, Yehong Hu, et al.
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 4, pp. 1235-1248
Closed Access
Protective effects of seed oil from Nicotiana tabacum L. On D-galactose induced liver and brain damages of mice by regulating PI3K/Akt/Nrf2 signaling pathway
Gu Ji, Yongchao Wang, Shanshan Xiao, et al.
Journal of Functional Foods (2024) Vol. 124, pp. 106628-106628
Open Access
Gu Ji, Yongchao Wang, Shanshan Xiao, et al.
Journal of Functional Foods (2024) Vol. 124, pp. 106628-106628
Open Access
